In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity.
In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity. Apply to Canadian consumer advertising for drugs, natural health products and foods with health claims.
In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity.
How can marketing teams comply?
Apply to Canadian consumer advertising for drugs, natural health products and foods with health claims.
In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity.
Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.
Alabama's medical cannabis program (Alabama Medical Cannabis Commission (AMCC)) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Arkansas's medical cannabis program (Arkansas Medical Marijuana Commission) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Hawaii's medical cannabis program (Hawaii Department of Health — Medical Cannabis Registry) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Iowa's medical cannabis program (Iowa Department of Health and Human Services (Iowa HHS), Office of Medical Cannabidiol) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Kentucky's medical cannabis program (Kentucky Cabinet for Health and Family Services — Office of Medical Cannabis) bars marketing that appeals to minors, promotes non-medical use or reaches people without a patient registration, or makes cure or safety claims.
Request a free compliance scan of your homepage and book a time with Warrant.